Navigation Links
Pre-Clinical Data Show Intracellular Pathways Affected by ONCONASE(R)
Date:2/21/2008

for ONCONASE to simultaneously switch on and off numerous genes controlling major regulatory processes in the cell life cycle, and underscores that ONCONASE works selectively and does not appear to kill cells indiscriminately," added Kuslima Shogen, Alfacell's chief executive officer. "This research represents an important step forward in our continuing efforts to create targeted ONCONASE fusion proteins and to bring them forward into the clinic."

About ONCONASE(R)

ONCONASE is a first-in-class product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells while sparing normal cells. ONCONASE triggers apoptosis, the natural death of cells, via multiple molecular mechanisms of action.

About Alfacell Corporation

Alfacell Corporation is the first company to advance a biopharmaceutical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials. The product candidate, ONCONASE, is an RNase that overcomes the challenges of targeting RNA for therapeutic purposes while enabling the development of a new class of targeted therapies for cancer and other life-threatening diseases. In addition to an ongoing Phase IIIb study in malignant mesothelioma, Alfacell is conducting a Phase I/II trial of

ONCONASE in non-small cell lung cancer (NSCLC) and other solid tumors. For more information, visit http://www.alfacell.com.

Safe Harbor

This press release includes statements that may constitute "forward- looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or c
'/>"/>

SOURCE Alfacell Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
2. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
3. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
4. Clinical Trial Participation Unaffected by Disclosure of Investigators Financial Stake, Food and Drug Law Journal Article Finds
5. Sexual Function Affected by Stem Cell Transplant According to Long-Term Study
6. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
7. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... LONDON , July 7, 2015 ... Sales Forecasts, Helping Your Influence  ,Are ... ? If so, now gain technological and commercial predictions ... authority. There explore trends in research and development, results, ... by visiongain shows you what,s possible for ...
(Date:7/7/2015)... , July 7, 2015  PAREXEL International Corporation (NASDAQ: ... and Fiscal Year 2015 on Wednesday, August 5 th , ... will be available on PAREXEL,s website at www.PAREXEL.com ... PAREXEL will host a conference call and live webcast ... 2015 to discuss the results.  To access the webcast, visit ...
(Date:7/7/2015)... SHENZHEN, China , July 7, 2015 /PRNewswire/ -- ... ), a leading developer, manufacturer and marketer of ... to acquire the remaining stake in Wuhan Dragonbio ... million. Dragonbio is a domestic ... joint and other surgical products. Prior to today,s ...
Breaking Medicine Technology:Biobanking for Medicine: Technology, Industry and Market 2015-2025 2Biobanking for Medicine: Technology, Industry and Market 2015-2025 3Biobanking for Medicine: Technology, Industry and Market 2015-2025 4Biobanking for Medicine: Technology, Industry and Market 2015-2025 5Biobanking for Medicine: Technology, Industry and Market 2015-2025 6Biobanking for Medicine: Technology, Industry and Market 2015-2025 7Biobanking for Medicine: Technology, Industry and Market 2015-2025 8Biobanking for Medicine: Technology, Industry and Market 2015-2025 9Biobanking for Medicine: Technology, Industry and Market 2015-2025 10PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2015 Earnings Release And Conference Call 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 3Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 4
... 13, 2010 Endologix, Inc. (Nasdaq: ELGX ... announced today that it has completed the acquisition of ... for the treatment of Abdominal Aortic Aneurysms (AAAs) that ... aneurysm repair (EVAR) devices and expand the global AAA ...
... Dec. 13, 2010 Bionovo, Inc. (Nasdaq: BNVI ... of innovative treatments for women,s health and cancer, today announced ... and Drug Administration,s (FDA) Clinical Guidance meeting that took place ... with the Company,s proposed overall clinical development plan. ...
Cached Medicine Technology:Endologix Completes Acquisition of Nellix 2Endologix Completes Acquisition of Nellix 3Endologix Completes Acquisition of Nellix 4Bionovo Releases FDA-Approved Clinical Development Plan for Menerba 2Bionovo Releases FDA-Approved Clinical Development Plan for Menerba 3Bionovo Releases FDA-Approved Clinical Development Plan for Menerba 4
(Date:7/7/2015)... ... , ... U.S. Rep. Mike Thompson (D-CA 5) introduced legislation ... available to Medicare beneficiaries. Thompson’s bill, the Medicare Telehealth Parity Act, was introduced ... and Peter Welch (D-VT). , “This bi-partisan legislation takes an important step forward ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... Silverado today ... break ground as early as Summer 2015 on a four-acre site in Bellingham, Washington. ... with the support of city officials and other members of the local community. , ...
(Date:7/7/2015)... MILWAUKEE and CHICAGO (PRWEB) , ... July 07, ... ... appointed healthcare business development and growth strategy expert Jay Warden as Senior Vice ... responsible for the company’s efforts to provide the best solutions to healthcare providers’ ...
(Date:7/7/2015)... ... July 07, 2015 , ... Dermatologists from the Mount ... (AIF), identifying 18 possible melanomas and 46 potential non-melanoma skin cancers (basal cell ... , The Aspen Ideas Festival, which was held from June 25 through July ...
(Date:7/7/2015)... NE (PRWEB) , ... July 07, 2015 , ... ... center for MRI services, is debuting their brand new website. The website’s goal ... technology and a wider selection of patient tools, including requesting appointments online. , ...
Breaking Medicine News(10 mins):Health News:The American Telemedicine Association Supports Legislation to Expand Medicare Coverage for Telemedicine Services 2Health News:New Silverado Memory Care Community Receives Unanimous Approval from Design Review Board 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 2Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 3Health News:More than 700 Screened for Skin Cancer at 2015 Aspen Ideas Festival 4Health News:Northeast Nebraska Imaging Launches New Patient Friendly Website 2
... Santana to ... Steps for Their Health, BOCA RATON, Fla., Sept. ... Carlos Santana footwear announce today the opening of,bidding for ... online,charity auction of celebrity-autographed footwear that will benefit several,health ...
... than 105 million Americans,have high cholesterol, according to ... National Cholesterol Month, and LifeMasters, a,leading national provider ... healthy blood cholesterol levels. Cholesterol, a fat-like ... and absorbed from food. The liver also makes ...
... 2007 Inc. 5,000, No. 58 in the ... 97.2%, PORTLAND, Ore., Sept. 5 Inc. magazine has ... on,its first-ever Inc. 5,000 list of the fastest-growing private companies ... annual Inc.,500 list, catches many businesses that are too big ...
... trials involving people are next step , , WEDNESDAY, Sept. ... dramatically cut the time needed to take effect when ... , The study authors, from McGill University in Montreal, ... into the family of drugs, raising the prospect of ...
... high risk of acquiring hepatitis C (HCV) and hepatitis ... do not become infected as quickly as they did ... the September issue of Hepatology, a journal published by ... Association for the Study of Liver Diseases (AASLD). The ...
... university Karolinska Institutet have now disclosed the mystery how ... sensing ion channel proteins on their surface. This mechanism, ... Metabolism, explains how the human body can keep the ... avoid the development of diabetes. , Blood sugar absorbed ...
Cached Medicine News:Health News:Online Celebrity Shoe Charity Auction for Women's Heart Health Opens Bidding 2Health News:Online Celebrity Shoe Charity Auction for Women's Heart Health Opens Bidding 3Health News:LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level 2Health News:LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level 3Health News:LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level 4Health News:First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion 2Health News:First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion 3Health News:First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion 4Health News:Experimental Antidepressants Offer Faster Relief 2Health News:HCV and HBV spreading more slowly among injection drug users in San Francisco 2Health News:Scientists explain how insulin secreting cells maintain their glucose sensitivity 2
... 5mm AEM Laparoscopic Instruments incorporate a layered ... are shielded and monitored to prevent stray ... instrument caused by insulation failure or capacitive ... protective shield built into all AEM Instruments ...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Medicine Products: